Argyle Capital Partners, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Argyle Capital Partners, LLC

  • $139 Billion
  • Q3 2025

A detailed history of Argyle Capital Partners, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Argyle Capital Partners, LLC holds 24,039 shares of XBI stock, worth $2.74 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares
24,039
Previous 25,884 7.13%
Holding current value
$2.74 Million
Previous $2.15 Billion 12.21%
% of portfolio
1.73%
Previous 1.77%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$83.08 - $100.2 $153,282 - $184,869
-1,845 Reduced 7.13%
24,039 $2.41 Billion
Q2 2025

Aug 13, 2025
SELL
$69.8 - $85.28 $75,453 - $92,187
-1,081 Reduced 4.01%
25,884 $2.15 Billion
Q1 2025

Aug 13, 2025
BUY
$81.1 - $94.7 $371,600 - $433,915
4,582 Added 20.47%
26,965 $2.19 Billion
Q4 2024

Aug 13, 2025
BUY
$89.81 - $104.0 $2.01 Million - $2.33 Million
22,383 New
22,383 $2.02 Billion

Others Institutions Holding XBI

# of Institutions
837
Shares Held
121M
Call Options Held
28.7M
Put Options Held
34.7M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Argyle Capital Partners, LLC Portfolio

Follow Argyle Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email